Medtronic has teamed up with Star Jones to get women talking about heart health. The TV personality is lending her star power ...

Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) both face patient lawsuits related to spinal cord stimulation (SCS) ...

Medtronic PLC closed 10.85% short of its 52-week high of $96.25, which the company reached on March 10th.

The medtech giant launched Medtronic Spark: a 10-year initiative designed to attract 1 million low-income students to careers ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent ...

The smaller Mobi pump for more active users was launched in 2024, and the Sigi patch pump is in development. With this range of products, we think it’s likely Tandem can address a wider swath of both ...

FDA approves Medtronic adaptive deep brain stimulation system for Parkinson's Disease NORTHAMPTON, MA / ACCESS Newswire / May 6, 2025 / Liza Bobrow didn't think it was a big deal when her ...

In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

Medtronic today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) technologies.